NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

放射性醫藥品的全球市場:2020∼2027年

Global Radiopharmaceuticals Market, Size, Share, Outlook and Growth Opportunities 2019-2026

出版商 DataM Intelligence 商品編碼 983411
出版日期 內容資訊 英文 180 Pages
商品交期: 約2個工作天內
價格
放射性醫藥品的全球市場:2020∼2027年 Global Radiopharmaceuticals Market, Size, Share, Outlook and Growth Opportunities 2019-2026
出版日期: 2021年04月03日內容資訊: 英文 180 Pages
簡介

全球放射性醫藥品的市場規模,預計從2019年到2026年的預測期間內,以9.2%的年複合成長率成長。

全球放射性醫藥品的市場規模,以踏實的步調成長,預計未來也相同快速成長。

市場成長,起因於診斷設施的改善,新的癌症病例數增加,癌症治療放射線治療的偏好高漲等要素。

再加上使用了放射性醫藥品和Alpha輻射免疫療法為基礎的標的癌症療法的影像技術開發,也是促進市場成長的重要要素。

全球放射性醫藥品市場,由於放射性醫藥品的半衰期短,醫藥品的供需缺口,影像診斷設備的設備價格高等要素,可能妨礙成長。

本報告提供全球放射性醫藥品市場相關調查分析,市場概要,市場成長的影響要素,各市場區隔、各地區的市場規模和與前一年同期比較成長,及主要企業等相關分析。

目錄

第1章 全球放射性醫藥品市場:調查手法、範圍

  • 調查手法
  • 調查目的和調查範圍

第2章 放射性醫藥品市場:市場定義、概要

第3章 放射性醫藥品市場:摘要整理

  • 市場明細:各放射性同位素
  • 市場明細:各應用領域
  • 市場明細:原料
  • 市場明細:各地區
  • 市場明細:各終端用戶

第4章 全球放射性醫藥品市場:市場動態

  • 影響市場的要素
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 全球放射性醫藥品市場:產業分析

  • 供應鏈分析
  • 價格分析
  • 值得注意的主要企業
  • 技術開發
  • 流行病學

第6章 全球放射性醫藥品市場:市場動態

  • PEST分析
  • 波特的五力分析
  • 產品採用率

第7章 全球放射性醫藥品市場:各放射性同位素

  • 簡介
  • 市場規模分析,及與前一年同期比較成長分析(%):各放射性同位素
  • 市場魅力指數:各放射性同位素
    • Tec.99
    • F18
    • 碘131
    • Reutetium 177
    • 釔90
    • 鎵68
    • 鎵67
    • 銣82
    • 碘123
    • 碘125
    • 銦111
    • 其他

第8章 全球放射性醫藥品市場:各應用領域

  • 簡介
  • 市場規模分析,及與前一年同期比較成長分析(%):各應用領域
  • 市場魅力指數:各應用領域
    • 腫瘤學
    • 心臟病
    • 胃腸病學
    • 神經內分泌學
    • 神經學
    • 腎臟學
    • 其他

第9章 全球放射性醫藥品市場:各原料

  • 簡介
  • 市場規模分析,及與前一年同期比較成長分析(%):各原料
  • 市場魅力指數:各原料
    • 犀牛巴豆
    • 核子反應爐

第10章 全球放射性醫藥品市場:各終端用戶

  • 簡介
  • 市場規模分析,及與前一年同期比較成長分析(%):各終端用戶
  • 市場魅力指數:各終端用戶
    • 醫院
    • 影像診斷中心
    • 外科門診診療所
    • 癌症研究

第11章 全球放射性醫藥品市場:各地區

  • 簡介
  • 市場規模分析及與前一年同期比較成長分析(%):各地區
  • 市場魅力指數:各地區
  • 北美
  • 歐洲
  • 南美
  • 亞太地區
  • 中東、非洲

第12章 全球放射性醫藥品市場:競爭情形

  • 競爭模式
  • 其他競爭公司的策略分析
  • 比較產品系列分析
  • 市場定位/佔有率分析
  • 合併和收購分析

第13章 企業簡介

  • GE Healthcare
    • 企業概要
    • 產品系列、說明
    • 主要的焦點
    • 財務概要
  • Mallinckrodt PLC
  • Siemens Healthineers
  • Eckert & Ziegler
  • Lantheus Medical Imaging, Inc.
  • Cardinal Health, Inc.
  • Bayer AG
  • Bracco Imaging S.P.A
  • Nordion, Inc
  • Advanced Accelerator Applications S.A.
  • IBA Radiopharma Solutions
  • Fujifilm Holdings Corporation
  • Ion Beam Applications
  • NorthStar Medical Radioisotopes, LLC
  • Synektik Group
  • ABX GmbH
  • Coqui Radiopharmaceuticals
  • Tema Sinergie
  • Curium
  • Jubilant Pharma LLC
  • PET Pharm Biotech Co. Ltd
  • Isorad Ltd
  • Sirtex

第14章 全球放射性醫藥品市場:重要考察

第15章 全球放射性醫藥品市場:DataM

  • 附錄
  • 關於本公司、服務
  • 諮詢方式

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Global Radiopharmaceuticals Market is segmented By Radioisotopes (Tec.99, F18, Iodine 131, Leutetium 177, Yttrium 90, Gallium 68, Gallium 67, Rubidium 82, Iodine 123, Iodine 125, Indium 111, Others), By Application (Oncology, Cardiology, Gastroenterology, Neuroendocrinology, Neurology, Nephrology, Others), By Source (Cyclotrons, Nuclear Reactor), By End User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, Cancer Research Institute), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Share, Size, Outlook, and Opportunity Analysis, 2019-2026

Market Overview

The Global Radiopharmaceuticals Market is expected to grow at a CAGR of 9.2% during the forecasting period (2019-2026).

Radiopharmaceuticals also known as Nuclear medicines are a group of pharmaceutical drugs which have radioactivity and can be used as diagnostic and therapeutic agents.

Radiopharmaceuticals emit radiation themselves, which is different from fluids within the body which absorb or alter external electromagnetism or ultrasound. This phenomenon helps to identify the various abnormalities such as cancer cells, within the human body.

Market Drivers and Restraints

Global radiopharmaceuticals market is growing at a steady pace and anticipated to exhibit similar faster growth in the future.

The market growth is attributed to driving factors such as improvements in diagnostic facilities, an increase in the number of new cancer cases, and an increase in preference for radiation therapy for cancer treatment.

Moreover, developments in imaging technologies using radiopharmaceuticals and alpha radioimmunotherapy-based targeted cancer treatment are also key factors fueling the growth of the market.

The global radiopharmaceuticals market might experience a hindrance in the growth owing to the short half-life of radiopharmaceuticals, supply-demand gap of the pharmaceuticals, and high equipment prices of diagnostic imaging devices.

Market Segementation

By End User

The Radiopharmaceuticals market is segmented on end user as Hospitals & Clinics, Diagnostic Centers, and Others. Diagnostic centers dominate the market share with more than 50% of the market share.

Other category includes primarily research centers which are driving the growth for Another end-user segment.

By geography

Based on the geography, North America is dominating the global Radiopharmaceuticals system market, and it is expected to grow in the forecast period.

The US is the most significant revenue contributor to this region because of an increase in the elderly population. Advances in technology in product, design, structure, and usage, development of various types of radiopharmaceuticals have contributed to the growth of the market in the US.

The Asia-pacific region is anticipated to be the fastest growing region in the global radiopharmaceuticals market. Technological innovations, growing elderly population, and improvements in healthcare infrastructure are the primary contributors to the growth of the market in Asia-Pacific.

Competitive Analysis

Several new players have entered into the global market for a radiopharmaceutical, and this trend denotes to the growing acceptance and popularity of dangerous drugs across the globe.

The market vendors that have earned a name for themselves in the global radiopharmaceuticals market have stuck to the basics of proper planning, marketing, and distribution of products. Established market vendors are recalibrating their business strategies to fit the needs and want of the consumers.

The distributors of dangerous drugs have also played a key role in reaching to wider audiences and expanding their consumer base. Product launch is one of the key strategy adopted by the principal manufacturers to improve their market presence across the globe.

For instance, In January 2018, Norgine B.V., a leading European specialty pharmaceutical company has announced the launch of LYMPHOSEEK® (Tc 99m tilmanocept) in Finland and Sweden. LYMPHOSEEK is a radiopharmaceutical used for diagnostic purposes by nuclear medicine specialists and surgeons.

Radio Pharmaceuticals Applications

1.Diagnostic Radioisotopes

Single-Photon Emission Computed Tomography (SPECT)

  • Technetium-99m
  • Thallium-201
  • Gallium-67
  • Iodine-23
  • Others

Positron Emission Tomography

  • Fluorine-18
  • Rubidium-82
  • Others

2.Therapeutic Radioisotopes

Beta Emitters

  • Iodine-131
  • Yttrium-90
  • Rhenium-186
  • Others

Alpha Emitters

  • Brachytherapy
  • Iodine-125
  • Cesium-131
  • Others

Reasons for purchasing this report?

  • Visualize the composition of the Radiopharmaceuticals market across each indication, regarding by type, by application, and by end user highlighting the vital commercial assets and players.
  • Identify business opportunities in Radiopharmaceuticals market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of the Radiopharmaceuticals market - level 4/5 segmentation
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study
  • Product mapping in excel for the Radiopharmaceuticals products of all major market players

Who can benefit from this report?

  • Raw Material Suppliers/ Buyers
  • Product Suppliers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturer

Related Reports:

Biopharmaceuticals Market

Active Pharmaceutical Ingredients Market

Table of Contents

Table of Contents

1 Global Radiopharmaceuticals Market Methodology and Scope

  • 1.1 Research methodology
  • 1.2 Research Objective and Scope of the Report

2 Global Radiopharmaceuticals Market - Market Definition and Disease Overview

3 Global Radiopharmaceuticals Market - Executive Summary

  • 3.1 Market Snippet by Radioisotopes
  • 3.2 Market Snippet by Application
  • 3.3 Market Snippet by Source
  • 3.4 Market Snippet by Region
  • 3.5 Market Snippet by End User 

4 Global Radiopharmaceuticals Market - Market Dynamics

  • 4.1 Market Impacting Factors 
    • 4.1.1 Drivers 
    • 4.1.2 Restraints 
    • 4.1.3 Opportunity
    • 4.1.4 Impact Analysis

5 Global Radiopharmaceuticals Market - Industry Forces

  • 5.1 Supply Chain Analysis 
  • 5.2 Pricing Analysis 
  • 5.3 Key Companies to Watch 
  • 5.4 Technology Development 
  • 5.5 Epidemiology

6 Global Radiopharmaceuticals Market - Market Dynamics 

  • 6.1 PEST Analysis 
  • 6.2 PORTERS Five Forces 
  • 6.3 Product Adoption Rate 

7 Global Radiopharmaceuticals Market - By Radioisotopes 

  • 7.1 Introduction 
  • 7.2 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Radioisotopes 
  • 7.3 Market Attractiveness Index, By Radioisotopes 
    • 7.1.1 Tec.99*
      • 7.1.1.1 Introduction 
      • 7.1.1.2 Market Size Analysis, US$ Mn, 2017-2026 and Y-o-Y Growth Analysis (%), 2018-2026
    • 7.1.2 F18
    • 7.1.3 Iodine 131
    • 7.1.4 Leutetium 177
    • 7.1.5 Yttrium 90
    • 7.1.6 Gallium 68
    • 7.1.7 Gallium 67
    • 7.1.8 Rubidium 82
    • 7.1.9 Iodine 123
    • 7.1.10 Iodine 125
    • 7.1.11 Indium 111
    • 7.1.12 Others

8 Global Radiopharmaceuticals Market - By Application

  • 8.1 Introduction
  • 8.2 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 8.3 Market Attractiveness Index, By Application
    • 8.3.1 Oncology*
      • 8.3.1.1 Introduction
      • 8.3.1.2 Market Size Analysis, US$ Mn, 2017-2026 and Y-o-Y Growth Analysis (%), 2018-2026
    • 8.3.2 Cardiology
    • 8.3.3 Gastroenterology
    • 8.3.4 Neuroendocrinology
    • 8.3.5 Neurology
    • 8.3.6 Nephrology
    • 8.3.7 Others

9 Global Radiopharmaceuticals Market - By Source

  • 9.1 Introduction
  • 9.2 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
  • 9.3 Market Attractiveness Index, By Source
    • 9.3.1 Cyclotrons*
      • 9.3.1.1 Introduction
      • 9.3.1.2 Market Size Analysis, US$ Mn, 2017-2026 and Y-o-Y Growth Analysis (%), 2018-2026
    • 9.3.2 Nuclear Reactor

10 Global Radiopharmaceuticals Market - By End User

  • 10.1 Introduction
  • 10.2 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 10.3 Market Attractiveness Index, By End User
    • 10.3.1 Hospitals*
      • 10.3.1.1 Introduction
      • 10.3.1.2 Market Size Analysis, US$ Mn, 2017-2026 and Y-o-Y Growth Analysis (%), 2018-2026
    • 10.3.2 Diagnostic Imaging Centers
    • 10.3.3 Ambulatory Surgical Centers
    • 10.3.4 Cancer Research Institute

11 Global Radiopharmaceuticals Market - By Region

  • 11.1 Introduction
  • 11.2 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 11.3 Market Attractiveness Index, By Region
    • 11.1.1 North America
      • 11.1.1.1 Introduction
      • 11.1.1.2 Key Region-Specific Dynamics
      • 11.1.1.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Radioisotopes
      • 11.1.1.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      • 11.1.1.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
      • 11.1.1.6 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
      • 11.1.1.7 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.1.1.1.1 U.S.A
      • 11.1.1.1.2 Canada
      • 11.1.1.1.3 Mexico
    • 11.1.2 South America
      • 11.1.2.1 Introduction
      • 11.1.2.2 Key Region-Specific Dynamics
      • 11.1.2.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Radioisotopes
      • 11.1.2.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      • 11.1.2.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
      • 11.1.2.6 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
      • 11.1.2.7 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.1.2.1.1 Brazil
      • 11.1.2.1.2 Argentina
      • 11.1.2.1.3 Rest of South America
    • 11.1.3 Europe
      • 11.1.3.1 Introduction
      • 11.1.3.2 Key Region-Specific Dynamics
      • 11.1.3.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Radioisotopes
      • 11.1.3.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      • 11.1.3.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
      • 11.1.3.6 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
      • 11.1.3.7 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.1.3.1.1 Germany
      • 11.1.3.1.2 U.K.
      • 11.1.3.1.3 France
      • 11.1.3.1.4 Italy
      • 11.1.3.1.5 Spain
      • 11.1.3.1.6 Russia
      • 11.1.3.1.7 Rest of Europe
    • 11.1.4 Asia Pacific
      • 11.1.4.1 Introductions
      • 11.1.4.2 Key Region-Specific Dynamics
      • 11.1.4.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Radioisotopes
      • 11.1.4.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      • 11.1.4.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
      • 11.1.4.6 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
      • 11.1.4.7 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.1.4.1.1 China
      • 11.1.4.1.2 India
      • 11.1.4.1.3 Japan
      • 11.1.4.1.4 Australia
      • 11.1.4.1.5 South Korea
      • 11.1.4.1.6 Rest of Asia Pacific
    • 11.1.5 Middle East and Africa
      • 11.1.5.1 Introductions
      • 11.1.5.2 Key Region-Specific Dynamics
      • 11.1.5.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Radioisotopes
      • 11.1.5.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      • 11.1.5.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
      • 11.1.5.6 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12 Global Radiopharmaceuticals Market - Competitive Landscape

  • 12.1 Competitive Scenario
  • 12.2 Competitor Strategy Analysis
  • 12.3 Comparative Product Portfolio Analysis
  • 12.4 Market Positioning/Share Analysis
  • 12.5 Mergers and Acquisitions Analysis

13 Company Profiles

  • 13.1 GE Healthcare*
    • 13.1.1 Company Overview
    • 13.1.2 Product Portfolio and Description
    • 13.1.3 Key Highlights
    • 13.1.4Financials Overview
  • 13.2 Mallinckrodt PLC
  • 13.3 Siemens Healthineers
  • 13.4 Eckert & Ziegler
  • 13.5 Lantheus Medical Imaging, Inc.
  • 13.6 Cardinal Health, Inc.
  • 13.7 Bayer AG
  • 13.8 Bracco Imaging S.P.A
  • 13.9 Nordion, Inc
  • 13.10 Advanced Accelerator Applications S.A.
  • 13.11 IBA Radiopharma Solutions
  • 13.12 Fujifilm Holdings Corporation
  • 13.13 Ion Beam Applications
  • 13.14 NorthStar Medical Radioisotopes, LLC
  • 13.15 Synektik Group
  • 13.16 ABX GmbH
  • 13.17 Coqui Radiopharmaceuticals
  • 13.18 Tema Sinergie
  • 13.19 Curium
  • 13.20 Jubilant Pharma LLC
  • 13.21 PET Pharm Biotech Co. Ltd
  • 13.22 Isorad Ltd
  • 13.23 Sirtex

14 Global Radiopharmaceuticals Market - Premium Analyst Insights

15 Global Radiopharmaceuticals Market - DataM

  • 15.1 Abbreviations and Assumptions
  • 15.2 About Us and Services
  • 15.3 Contact Us